Wang‐Zhong Li
Impact in
- Otorhinolaryngology top 2%
- Head and Neck Cancer Studies
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Viral-associated cancers and disorders
Papers in
-
- Head and Neck Cancer Studies 28
- Oncology 25
- Cancer Immunotherapy and Biomarkers 5
- Viral-associated cancers and disorders 4
- Global Cancer Incidence and Screening 3
Wang‐Zhong Li
40 papers receiving 522 citations
Hit Papers
Peers
Comparison fields: 5 of 72
- Otorhinolaryngology 205
- Oncology 275
- Hepatology 54
- Cancer Research 71
- Pulmonary and Respiratory Medicine 116
Countries citing papers authored by Wang‐Zhong Li
This map shows the geographic impact of Wang‐Zhong Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wang‐Zhong Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wang‐Zhong Li more than expected).
Fields of papers citing papers by Wang‐Zhong Li
This network shows the impact of papers produced by Wang‐Zhong Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wang‐Zhong Li. The network helps show where Wang‐Zhong Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Wang‐Zhong Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 2 | |
| 4 | Global cancer statistics for adolescents and young adults: population based study Hit paper breakdown → | 2024 | 41 |
| 5 | 2024 | 2 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 4 | |
| 8 | 2023 | 0 | |
| 9 | 2023 | 3 | |
| 10 | 2022 | 1 | |
| 11 | 2022 | 11 | |
| 12 | 2022 | 1 | |
| 13 | 2021 | 14 | |
| 14 | 2021 | 5 | |
| 15 | 2021 | 20 | |
| 16 | 2021 | 52 | |
| 17 | 2021 | 9 | |
| 18 | 2021 | 39 | |
| 19 | 2020 | 14 | |
| 20 | 2018 | 40 |
About Wang‐Zhong Li
Wang‐Zhong Li is a scholar working on Otorhinolaryngology, Oncology, Pulmonary and Respiratory Medicine, Cancer Research and Hepatology, having authored 41 papers that have together received 523 indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (28 papers), Lung Cancer Treatments and Mutations (9 papers), Head and Neck Surgical Oncology (7 papers), Cancer Immunotherapy and Biomarkers (5 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers), Viral-associated cancers and disorders (4 papers), Cancer-related molecular mechanisms research (4 papers) and Global Cancer Incidence and Screening (3 papers). The work is most often cited by research in Otorhinolaryngology (205 citations), Oncology (275 citations), Hepatology (54 citations), Cancer Research (71 citations) and Pulmonary and Respiratory Medicine (116 citations). Wang‐Zhong Li has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Yan‐Qun Xiang, Guoying Liu, Hu L, Wei‐Xiong Xia, Xing Lv, Xiang Guo, Shu‐Hui Lv, Wen‐Ze Qiu, Changqing Xie and Chao An. Their work appears in journals such as Journal of Clinical Oncology, Frontiers in Oncology, Frontiers in Immunology, Journal of Inflammation Research and Cancer Management and Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.